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Abstract
Background: The elongase of long chain fatty acids family 6 (ELOVL6) is an enzyme that specifically catalyzes the elongation
of saturated and monounsaturated fatty acids with 12, 14 and 16 carbons. ELOVL6 is expressed in lipogenic tissues and it is
regulated by sterol regulatory element binding protein 1 (SREBP-1).
Objective: We investigated whether ELOVL6 genetic variation is associated with insulin sensitivity in a population from
southern Spain.
Design: We undertook a prospective, population-based study collecting phenotypic, metabolic, nutritional and genetic
information. Measurements were made of weight and height and the body mass index (BMI) was calculated. Insulin
resistance was measured by homeostasis model assessment. The type of dietary fat was assessed from samples of cooking
oil taken from the participants’ kitchens and analyzed by gas chromatography. Five SNPs of the ELOVL6 gene were analyzed
by SNPlex.
Results: Carriers of the minor alleles of the SNPs rs9997926 and rs6824447 had a lower risk of having high HOMA_IR,
whereas carriers of the minor allele rs17041272 had a higher risk of being insulin resistant. An interaction was detected
between the rs6824447 polymorphism and the intake of oil in relation with insulin resistance, such that carriers of this minor
allele who consumed sunflower oil had lower HOMA_IR than those who did not have this allele (P=0.001).
Conclusions: Genetic variations in the ELOVL6 gene were associated with insulin sensitivity in this population-based study.
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Introduction
The prevalence of obesity, type 2 diabetes mellitus and risk
factors associated with the metabolic syndrome (MS) has increased
dramatically over the past 30 years [1,2]. Insulin resistance is
associated with obesity and is the main indicator of early stages of
type 2 diabetes [3]. Intracellular lipid accumulation in non-adipose
tissue, such as liver and skeletal muscle, is one of the most likely
causes of dysfunction of these tissues with regards to insulin
resistance [4–6]. De novo lipogenesis is a key event for energy
metabolism and insulin sensitivity in the liver [7]. Proper elongation
and desaturation of fatty acids are essential to the maintenance of
lipid homeostasis and disruption of these processes may have
important consequences [8]. The elongase of long chain fatty acids
family 6 (ELOVL6) is an enzyme which specifically catalyzes the
elongation ofsaturated and monounsaturated fattyacidswith12,14
and 16 carbons [9]. ELOVL6 is expressed in lipogenic tissues and
regulated bysterolregulatoryelement bindingprotein 1 (SREBP-1).
Matsuzaka et al demonstrated in Elovl6 2/2 mice that the loss of
Elovl6 function protected from high-fat induced hyperinsulinemia,
hyperglycemia and hyperleptinemia, the fundamental signs of obesity
and diabetes, despite the development of obesity and hepatosteatosis
[10]. This maintenance of whole-body insulin sensitivity in
Elovl6 2/2 mice is attributed to continuous signalling through the
hepatic IRS-2/Akt pathway, an effect suggested to be mediated by the
increased ratio of C16:1 n-7 to C16:0 in the liver [11]. Inhibition of this
elongase could be a new therapeutic approach for ameliorating insulin
resistance and diabetes, even in the presence of obesity.
To date, all studies on the role of Elovl6 have been undertaken
in animal models [10,12] or are in vitro studies [13]. As far as we
are aware, no study has yet been done on ELOVL6 genetic
variation in a human population and its possible association with
insulin resistance or obesity-related disorders.
We analyzed five SNPs of the ELOVL6 gene using a
population-based cohort of persons older than 18 years of age
(men and women) in southern Spain, and gathered phenotypic,
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21198metabolic, nutritional and genetic information. This is the first
study to test the hypothesis that ELOVL6 genetic variation is
associated with insulin sensitivity.
Materials and Methods
The Pizarra Study
The Pizarra Study is a prospective, population-based cohort
study among 1051 subjects aged 18–65 years from Pizarra, a town
in the province of Malaga (Andalusia, southern Spain). The study
was designed to investigate the incidence and determinants of
metabolic disorders, such as type 2 diabetes and obesity. The
rationale and design have been described previously [14–18].
Informed consent was obtained from each participant, and the
study was approved by the medical ethics committee of Carlos
Haya Regional University Hospital of Malaga. At baseline (1997–
1998), all the participants were interviewed and underwent a
standardized clinical examination. The same methods were used
at the follow-up study (2003–2004).
Measures
The same methods were used for both the prevalence study and
the incidence study. Standardized measurements were made of
weight, height and body mass index (BMI). Persons were
considered to be obese if their BMI was 30 kg/m
2.
The serum was stored at 270uC for later analysis. Blood glucose
was measured in both studies using the glucose oxidase method
(Bayer, Leverkusen, Germany) at fasting and 120 minutes after an
OGTT with 75 g of glucose. Insulinemia at baseline and 120 min
after an oral glucose load was measured by radioimmunoassay
(Coat-a-Count Insulin, DPC, Los Angeles, CA, USA). Insulin
resistance was determined with the formula for the homeostasis
model assessment (HOMA_IR) [19]: Fasting insulin (pmol/l) 6
fasting glucose (mmol/l)/22.5.
Enzymatic methods were used to measure total cholesterol,
triglycerides and high-density lipoprotein cholesterol in each
sample.
For the baseline study, a sample was taken of the cooking oil
being used by a random subset of 538 persons. To avoid the oil
being swapped for newer oil, the family was unaware of the
intention to request a sample of their oil until the time of the visit
by the investigator. All the participants authorized the collection of
their cooking oil. The fatty acid composition of the cooking oil was
analyzed by gas chromatography [16]. Cooking oil samples were
classified according to their fatty acid composition. Considering
that only olive and sunflower oils are commercialized in Spain for
domestic use, three groups of oils were defined: oils with levels of
linoleic acid higher than 50% were classified as sunflower oils, oils
with less than 25% linoleic acid were classified as olive oil, and oils
containing between 25–50% linoleic acid were classified as
mixtures.
DNA extraction and genotyping
Genomic DNA was isolated from peripheral blood using
automatic DNA extraction (MaxwellH16 Instrument, Promega)
according to the manufacturer’s recommended protocols. DNA
was quantified using the RediPlate
TM 96 PicoGreenHystem kit
from Molecular Probes and diluted to a final concentration of
10 ng for genotyping.
Five SNPs were selected for genotyping based on their
frequency in a Caucasian population (MAF.0.05), their known
or possible functional effect, and their position and spacing along
the ELOVL6 gene. This information was obtained from the
HapMap database (available at http://www.hapmap.org).
SNPs were analyzed by SNPlex (genotyping system based on
oligo-ligation assay/polymerase chain reaction technology; Ap-
plied Biosystems, Foster City, California, USA).
Statistical analysis
Hardy-Weinberg equilibrium (HWE) of the five ELOVL6 SNPs
was tested using a chi-square test. The continuous variables are
shown as the mean and standard deviation and the classification
variables as proportions. Calculation of the statistical difference
between the means of the continuous variables was done by one-
way ANOVA and the qualitative variables by the x2 test. The
strength of association between variables was measured by
calculating the odds ratio (OR) and 95% confidence intervals by
logistic regression. The multivariate logistic regression model was
controlled for potential confounders such as age and sex. In all
cases the level of rejection of a null hypothesis was a=0.05 for two
tails. The data were analyzed with the gene analysis program R
SNPassoc [20] (version 1.5.8) of the R statistical software, version
2.8.1 (Department of Statistics, University of Auckland, Auckland,
NZ; http://www.r-project.org/).
Haplotypes were estimated using also the haplo.stats R package.
Haplotypes with frequencies lower than 0.05 were grouped as
rare. Linkage disequilibrium between polymorphisms was evalu-
ated by Haploview software version 4.1 (http://www.broad.mit.
edu/mpg/haploview).
Results
General characteristics
Information on the selected SNPs is shown in Table 1. Linkage
disequilibrium plot for the five SNPs studied is represented in
Figure S1.
The baseline and follow-up characteristics of the study
population are presented in Table 2. In total, 824 persons
Table 1. Characteristics of ELOVL6 SNPs studied.
Name Consequence Sequence HGVS Names
MAF* Pizarra
Study
rs3813825 3PRIME_UTR,DOWNSTREAM CTTCCTCCTG[T/A]TTGACACTTT NT_016354.18:g.35515815T.A 0.205
rs17041272 3PRIME_UTR,DOWNSTREAM GGTTAGAAAC[G/C]GAAGTGAGCA NT_016354.18:g.35518228C.G 0.058
rs4141123 INTRONIC AGTTAATTCT[A/G]TAAAATGAAA NM_024090.1:c.374–747G.A 0.397
rs9997926 INTRONIC AATGAGCTCA [C/T] GGTTTTCTGC NT_016354.19:g.35524800C.T 0.103
rs6824447 UPSTREAM ATAATAAGGA[A/G]CCCTGCTTTT NT_016354.18:g.35668859G.A 0.476
*MAF: minor allele frequency.
doi:10.1371/journal.pone.0021198.t001
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78.5%. Allele and genotype distributions of the 5 SNPs of the
ELOVL6 gene followed Hardy-Weinberg equilibrium proportions
(P.0.01).
Relation of ELOVL6 variants with HOMA_IR
Table 3 shows the relationship of the ELOVL6 SNPs with the
Homeostasis Model Assessment insulin resistance index (HO-
MA_IR), insulin and glucose levels at 120 minutes at baseline and
in the follow-up study, and the incidence of insulin resistance
according to genetic variation. The SNPs rs3813825 and
rs9997926 showed a significant association with HOMA_IR at
baseline and follow-up study, respectively. To evaluate the
influence of the polymorphisms on the risk of having high
HOMA_IR values, we selected those persons who had HO-
MA_IR below the 75th percentile and without type 2 diabetes at
baseline. Those persons who had the minor allele (T) of rs9997926
polymorphism had a lower risk of developing insulin resistance six
years later (OR=0.5; CI=0.29–0.9).
Subjects homozygous for the rare allele of rs3813825 (A) had
higher insulin and glucose values at 120 minutes in both studies
(baseline and follow-up). The rs9997926 polymorphism was also
significantly associated with insulin values at 120 minutes in the
Table 2. General characteristics of the study population*.
Baseline study
(n=824)
Follow-up study
(n=824)
Age (years) 40.6613.4 46.7613.9
Sex (male/female) (%) 36.4/63.6 36.4/63.6
BMI(weight/height
2)(Kg/m
2) 27.665.0 28.765.2
Baseline glucose (mg/dl) 96.3623.4 96.2623.0
Baseline insulin (mU/ml) 10.467.7 9.067.5
Triglycerides (mg/dl) 107.2676.1 99.5667
Total cholesterol (mg/dl) 199.1643.2 202.7639.7
HOMA IR 2.762.4 2.562.4
HOMA_75 (%)
{ 37.1 39.9
Obesity (%) 29.3 36.3
Intake of olive oil (%) 75.2% ------
*Persons who completed both the baseline and follow-up studies.
{HOMA75: persons who had HOMA IR above the 75th percentile.
Data are means 6 SD or proportions (%).
Obesity: BMI $30 kg/m
2.
doi:10.1371/journal.pone.0021198.t002
Table 3. Glucose levels, insulin levels and HOMA75 in baseline and follow up study according to SNP distribution.
Baseline study Follow-up study
Incidence of
HOMA75
{
Insu_120 Gluc_120 HOM75% (%) Insu_120 Gluc 120 HOM75% (%) (%)
Rs3813825
TT 50646 b 118632 ab 33.7 b 43641 118638 b 38.5 28.3
AT 47640 b 116632 b 36.9 b 38631 114632 b 39.6 24.4
AA 77653 a 132645 a 60.0 a 57680 139663 a 53.1 33.3
Rs17041272
CC 51646 118633 36.0 42641 117637 39.0 25.9
*
CG 50634 120633 34.9 45638 123644 47.1 38.9
GG 53631 116656 60.0 41621 109617 40.0
Rs4141123
AA 56641 122638 38.9 48655 119642 41.5 26.3
AG 52645 117631 38.7 40637 118639 39.3 25.6
GG 48645 118633 31.1 42637 117634 40.1 30.2
Rs9997926
CC 50645 118633 35.6 43640 119638 42.1 a 29.8
*
CT 52647 117633 34.0 38634 117640 29.9 b 17.9
TT 66630 130621 60.0 896103 122632 40.0 ab
Rs6824447
AA 52645 119634 40.7 42634 119635 44.9 32.8
AG 50642 118632 32.4 41641 118638 36.9 24.9
GG 52650 118634 36.4 45647 118640 40.4 25.5
{Persons who had HOMA IR below the 75th percentile and without type 2 diabetes at the baseline study and who had HOMA IR above the 75th percentile six years
later.
Insu_120= insulin at 120 min after an oral glucose load; Gluc_120=glucose at 120 min after an oral glucose load.
*P,0.05. Chi_square test.
Values with different letters are significantly different (P,0.05). ANOVA test.
Insulin (mU/ml), glucose (mg/dl).
doi:10.1371/journal.pone.0021198.t003
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associated with the baseline levels of insulin at the initial study.
None of the five SNPs was associated with baseline insulin and
glucose levels (data not shown).
ELOVL6 variants and risk of insulin resistance
Table 4 shows the odds ratio (OR) and 95% CI for the risk of
developing insulin resistance (HOMA_IR above the 75th
percentile) compared with having HOMA_IR values below the
75th percentile for the five ELOVL6 SNPs in the follow-up study.
Carriers of the minor allele of rs9997926 (T) had a lower risk of
having high insulin resistance values, after adjusting for age, sex
and the presence of obesity (OR=0.54; CI=0.320.8). After
adjusting for oil intake (olive vs. sunflower), the minor alleles of the
rs17041272 and rs6824447 polymorphisms were significantly
associated with the risk of being insulin resistant but with effects
in opposite directions. We also found a significant interaction
between oil intake and both polymorphisms. Figure 1 shows the
interaction between rs6824447 and oil intake. Subjects homozy-
gous for the rare allele of rs6824447 (GG) and who consumed
sunflower oil had lower insulin resistance values than subjects with
the AA or AG genotypes. However, no significant difference was
found in those persons who consumed olive oil between the
various genotypes (P interaction =0.001, adjusted for age and
sex). A similar finding was observed with the rs17041272
polymorphisms, although this effect only occurred in men (P
interaction for men =0.04; data not shown).
Table 5 presents the risk for having high values of insulin
resistance after six years in those persons who had HOMA_IR values
below the 75th percentile in the baseline study. As with the findings in
the follow-up study, carriers of the minor allele of rs17041272 (allele
G) had a higher risk for developing insulin resistance compared with
non-carriers (or for having HOMA_IR above the 75
th percentile).
The rs9997926 and rs6824447 SNPs again showed a protective effect
against developing insulin resistance, after also adjusting for age, sex,
the presence of obesity and oil intake.
Haplotypes and insulin resistance
We constructed haplotypes with those polymorphisms that were
significantly associated with insulin resistance in our study. Three
haplotypes with a frequency of .0.05 were estimated (Table 6).
The most common haplotype (frequency=0.459) was used as the
reference (Haplo Base). Those haplotypes with a frequency lower
than 0.05 were considered as rare haplotypes and they were
grouped in one category (hap.rare). Haplotype II was significantly
associated with insulin resistance in the follow-up study
(OR=0.54; p=0.01), with a protective effect. After adjustment
for oil intake, haplotype II (TGC) still remained significant, but
Table 4. Risk of having high values of HOMA_IR (above the 75th percentile) at the follow-up study according to ELOVL6 SNPs.
Model 1* Model 2
{
OR* (95% CI) P cod P dom P additive OR
{ (95% CI) P cod P dom P additive
Rs3813825
TT 1.0 NS NS NS 1.0 NS 0.06 0.04
AT 1.1(0.8–1.5) 1.4 (0.8–2.3)
AA 2.3 (098–5.5) 2.3 (0.6–8.5)
Rs17041272
CC 1.0 NS NS NS 1.0 0.02 0.007 0.01
CG/GG 1.3 (0.8–2.2) 2.6 (1.2–5.4)
Rs4141123
AA 1.0 NS NS NS 1.0 NS NS NS
AG 1.04 (0.7–1.4) 1.5 (0.9–2.5)
GG 1.1 (0.7–1.8) 1.6 (0.8–3.1)
Rs9997926
CC 1.0 0.03 0.01 0.01 1.0 NS NS NS
CT 0.5 (0.3–0.8) 0.5 (0.2–1.1)
TT 0.4 (0.1–1.7) 0.3 (0.04–2.4)
Rs6824447
AA 1.0 0.05 0.03 NS 1.0 0.01 0.008 0.006
AG 0.6 (0.4–0.9) 0.5(0.3–0.9)
GG 0.8 (0.5–1.3) 0.4 (0.2–0.8)
Logistic regression model.
*Adjusted for age, sex and presence of obesity.
{Adjusted for age, sex, presence of obesity and intake of oil (olive vs sunflower).
P cod: P value for codominant model.
P dom: P value for dominant model.
The codominant model compared the heterozygotes and the homozygotes for the least frequent allele to the homozygotes for the most frequent allele. The dominant
model compared a combination of the heterozygous and homozygous genotypes for the least frequent allele to the most frequent homozygous genotypes. The log-
additive model is equivalent to calculating the odds ratio for the risk allele.
doi:10.1371/journal.pone.0021198.t004
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(CGC) reached statistical significance (OR=0.69; CI=0.47–0.99;
P=0.04) (Table 7).
Discussion
This study shows, for the first time, that genetic variations in the
ELOVL6 gene are related with insulin sensitivity in a population
from southern Spain. The SNPs rs9997926 and rs6824447 appear
to improve insulin sensitivity, noting in our study population that
those persons who had the minor alleles of these SNPs had a lower
risk of having high HOMA_IR values, whereas those persons who
had the minor allele of rs17041272 had a greater risk of being
insulin resistant. This effect was seen in both the cross-sectional
study and the prospective study.
This study was undertaken in a population of whom 75%
consume olive oil, either as the sole source of vegetable fat (50%),
or else mixed with sunflower oil (25%); the remaining 25% just use
sunflower oil [21]. In this study we tested the effect of the intake of
olive oil on the association between the ELOVL6 gene and insulin
sensitivity. The results show that the intake of fat (olive oil vs.
sunflower oil) modifies the effect of the polymorphisms on insulin
resistance, such that those SNPs that were not significant become
so after considering the type of oil, thereby implying an interaction
between the two factors.
The endogenous synthesis of fatty acids is a crucial step in
maintaining lipid homeostasis and an alteration of these pathways
can lead to important metabolic changes. More and more
pathophysiological syndromes are being related with alterations
in lipid homeostasis, and study of the enzymes involved in these
processes is taking on increasing importance [8]. Very recent
murine studies have shown the importance of the role of Elovl6 in
energy metabolism and insulin sensitivity [10–12]. Matsuzaka et al
showed that deletion of Elovl6 in a mouse model prevents the
development of diet-induced insulin resistance, without ameliora-
tion of obesity or hepatosteatosis [10]. This deficiency affects not
Table 5. Incidence of HOMA75 after six years in those persons who had HOMA_IR values below the 75th percentile at the baseline
study.
Model 1* Model 2
{
OR (95% CI) P dom P additive OR(95% CI) P dom P additive
Rs3813825
TT 1.0 NS NS 1.0 NS NS
AT+AA 0.8 (0.5–1.5) 1.2 (0.6–2.3)
Rs17041272
CC 1.0 0.07 0.08 1.0 0.005 0.008
CG+GG 1.8 (0.9–3.3) 3.6 (1.2–7.2)
Rs4141123
GG 1.0 NS NS 1.0 NS NS
AG+AA 0.9 (0.5–1.6) 0.9 (0.5–1.8)
Rs9997926
CC 1.0 0.04 0.02 1.0 0.01 0.008
CT+TT 0.5 (0.3–1.0) 0.3 (0.08–0.8)
Rs6824447
AA 1.0 NS NS 1.0 0.04 0.01
AG+GG 0.7 (0.4–1.3) 0.4 (0.2–0.9)
Logistic regression model.
*Adjusted for age, sex and presence of obesity.
{Adjusted for age, sex, presence of obesity and intake of oil (olive vs sunflower).
P dom: P value for dominant model.
The dominant model compared a combination of the heterozygous and homozygous genotypes for the least frequent allele to the most frequent homozygous
genotypes. The log-additive model is equivalent to calculating the odds ratio for the risk allele.
doi:10.1371/journal.pone.0021198.t005
Figure 1. HOMA_IR values by rs6824447 genotypes and intake
of oil (olive vs sunflower). Means were adjusted for age, sex and
obesity. The P value shown was obtained for the interaction between
rs6824447 and intake of oil in a multivariate ANOVA model.
doi:10.1371/journal.pone.0021198.g001
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oxidation. Matsuzaka et al suggest that the reduction in insulin
resistance in Elovl6 deficient mice could take place via restoration
of hepatic insulin sensitivity by phosphorylation of Akt in the liver.
Elovl6 deficiency alters hepatic fatty acid composition; changes in
fatty acid chain length (decrease in long-chain fatty acids longer
than C18) and the ratio of fatty acids (C18:0/C16:0, C16:1/
C16:0) could reduce SREBP-1 and PPARa in the liver. Reduction
in SREBP-1 leads to decreased fatty acid synthesis via reduction of
lipogenic gene expression and increases in IRS-2 levels expression
and insulin sensitivity. Reduction in lipogenesis could lead to
decreased hepatic diacylglycerol content, which would lead to
decreased PKCe activity and increased insulin sensitivity [8,11].
Several studies have shown that Elovl6 expression is regulated
by many dietary, hormonal and developmental factors [22,23].
This elongase is also regulated by SREBP-1 [12], which in turn is
regulated by the PUFA [24]. SREBP-1c plays a crucial role in the
dietary regulation of most hepatic lipogenic genes. Matsuzaka et al
showed that the mRNA levels of fatty acyl-CoA elongase (FACE)
were suppressed in livers from fasted SREBP-1 wild-type mice and
markedly activated by refeeding in the wild-type mice, showing
nutritional regulation of FACE as a lipogenic enzyme. Similar
results were reported by Wang et al [23] in Elovl6 expression levels
in the liver of fasted rats that were later refed. Like Matsuzaka,
these authors also saw that the PUFA suppressed the expression of
lipid enzymes, including Elovl6. FACE mRNA levels are markedly
increased in a refed state after fasting in the liver and adipose
tissue. This refeeding response is significantly reduced in SREBP-1
deficient mice. Dietary PUFAs caused a profound suppression of
this gene expression, which could be restored by SREBP-1c
overexpression [12].
The diet in our study population is characterized by a high
intake of monounsaturated fatty acids (mainly oleic acid). In this
study we found an interaction between the intake of fat (olive oil
vs. sunflower oil) and some of the polymorphisms of the ELOVL6
gene in relation to insulin sensitivity. In the case of rs6824447,
those subjects with the AA genotype who consumed sunflower oil
had higher HOMA_IR values than those who consumed olive
oil, whereas these values fell very significantly in the carriers of
the minor allele who consumed sunflower oil, there being no
variation in the subjects who consumed olive oil. Although the
few studies on the nutritional regulation of Elovl6 expression
focus on the role of PUFA [12,25], the effect noted in our study
via the MUFA could indirectly reflect the reduction in the levels
of PUFA, which in the end would result in a change in the
proportion of certain fatty acids, thus affecting the maintenance
of lipid homeostasis.
This is the first study to examine the association between genetic
variation of the ELOVL6 gene and insulin sensitivity in humans,
measured by HOMA as well as hyperinsulinemia at 120 minutes
after the OGTT. The causes of postprandial hyperglycemia are
influenced by many factors which include a rapid flux of glucose
from the gut, impaired insulin release, endogenous glucose
production by the liver and peripheral insulin resistance [26,27].
Our results are in line with those found in animal models and in
vitro studies, in which less enzyme activity is associated with better
insulin sensitivity. In addition, this study also shows the effect that
diet (type of oil consumed) can have on gene function, as was
shown in the studies of Matsuzaka and Wang [12,22,23].
Table 7. Association analysis between haplotypes and HOMA_IR.
rs9997926 rs6824447 rs17041272 Freq. OR (95% CI) P value
Unadjusted model
Haplo Base C A C 0.458 1.00 (Reference haplotype)
Hap I C G C 0.379 0.91(0.73–1.2) NS
Hap II T G C 0.065 0.54(0.32–0.86) 0.01
Hap rare * * * 0.096 0.95(0.66–1.37) NS
Adjusted model
{
Haplo Base C A C 0.468 1.00(Reference haplotype)
Hap I C G C 0.381 0.69(0.47–0.99) 0.04
Hap II T G C 0.053 0.42(0.17–1.02) 0.05
Hap rare * * * 0.097 1.5(0.84–2.67) 0.17
Sunflower vs olive il 2.26(1.34–3.81) 0.002
Age 1.05(1.03–1.07) ,0.001
Sex 0.87(0.54–1.41) 0.58
Logistic regression model. Dependent variable: HOMA_ IR above or below the 75th percentile of the distribution of HOMA IR in the persons with OGTT-N (0= HOMA IR
#75th percentile; 1= HOMA IR.75th percentile).
{Model adjusted for age, sex and oil intake.
doi:10.1371/journal.pone.0021198.t007
Table 6. Haplotypes estimated in the ELOVL6 gene and
observed frequencies in the Pizarra study.
rs17041272
(C/G)
rs6824447
(A/G)
rs9997926
(C/T) Frequency
Haplotype 1 C A C 0.459
Haplotype 2 C A T 0.037
Haplotype 3 C G C 0.380
Haplotype 4 C G T 0.065
Haplotype 5 G A C 0.027
Haplotype 6 G A T 0
Haplotype 7 G G C 0.03
Haplotype 8 G G T 0
doi:10.1371/journal.pone.0021198.t006
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results that were consistent both cross-sectionally and prospective-
ly. These results show that genetic variations in the ELOVL6 gene
influence insulin sensitivity in humans. Nevertheless, an important
limitation of the study concerns the choice of the SNPs, as these
are in linkage disequilibrium with others that could, in fact,
account for our findings. Thus, a more profound study of the gene
is required in order to detect possible functional variants. The lack
of information about the functionality of the genetic variants
impedes conclusions from our study as to whether the minor alleles
of the SNPs studied are associated with more or less enzyme
activity. Nonetheless, from the information currently available and
based on our own findings, we can speculate that the SNPs
rs9997926 and rs6824447 are related with some functional variant
that reduces Elovl6 activity whereas rs17041272 could be linked to
a functional variant with the opposite effect. Other limitation of
the study concerns the sample size, more studies in bigger
population would be necessary to confirm these data.
In summary, we found that carriers of the minor alleles
rs9997926 and rs6824447 of the ELOVL6 gene have lower insulin
resistance than non-carriers and this effect is not independent of
the type of oil consumed. This study supports the results of
Matsuzaka, suggesting the importance not only of the degree of
fatty acid saturation but also of their length on energy metabolism
and insulin sensitivity. The experimental results together with
those reported here suggest that the ELOVL6 gene could be a
future therapeutic target in the treatment of diabetes and related
disorders.
CIBER de Diabetes y Enfermedades Metabo ´licas Asociadas is
an ISCIII project.
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